The NIHR Manchester Biomedical Research Centre (BRC) is a collaboration between the University of Manchester and six leading local NHS organisations, that brings together academics and clinicians to translate scientific breakthroughs into potential new treatments, diagnostics and medical technologies for the benefit of patients, the public, and the health and care system.
In 2022, the Manchester BRC was awarded £59.1 million to deliver high-quality early translational and experimental research across a number of specialist areas. We are delighted that one of the research themes funded as part of this new Manchester BRC was Rare Conditions.
BRC Rare Conditions Theme
In partnership with the MRCC, the Manchester BRC Rare Conditions Theme aims to employ a range of multi-disciplinary experimental approaches to drive innovation in the prevention, diagnosis and treatment of rare conditions.
Our rare conditions theme contains three programmes:
- Improved diagnosis, understanding and prevention of rare conditions
- Understanding the impacts and outcomes of rare conditions
- Novel treatments for rare conditions